LIXTE Biotechnology Holdings will be added to the Russell Microcap Index effective after market close on June 26, with inclusion taking effect at trading open on June 29. Management says the listing will raise institutional visibility, support its AI energy infrastructure platform and boost shareholder value after its strategic transformation.
LIXTE will be added to the Russell Microcap Index after market close on June 26, with new membership effective at the open of trading on June 29. The annual reconstitution process reflects changes in the U.S. equity market and adds small-cap companies meeting Russell’s eligibility standards.
Membership in the Russell Microcap Index is projected to heighten LIXTE’s profile among institutional and passive investors, potentially improving trading liquidity and generating additional demand for its shares.
LIXTE has shifted from oncology therapies to an AI energy infrastructure equipment and services platform, targeting the growing power and infrastructure needs of cloud computing and hyperscale data center operators as AI demand accelerates.
